New Jersey · 86146

Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement in New Jersey

New Jersey Medicare Avg
$24.91
1% above national avg
National Medicare Avg
$24.72
All states combined
Billed Charge (NJ)
$115.99
What providers submit
Est. Commercial (NJ)
$63.53
National avg: $55.38
Est. Cash / Self-Pay (NJ)
$50.58
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

23.7K
Services in NJ
34
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New Jersey

Provider Medicare Services
Quest Diagnostics Incorporated $24.94 8.8K
Bioreference Health, Llc $24.87 8.3K
Laboratory Corporation Of America... $24.93 5.1K
Accu Reference Medical Lab, Llc $24.94 843
Ez Clinical Laboratory Inc $24.94 117
Centers Lab Nj Llc $24.94 72
Fahima, Dewan $24.94 60
Gonter, Neil MD $24.94 60
Novalab Corp $24.94 55
Lee, Linda MD $24.94 48
Lieberman, Eric MD $24.94 34

New Jersey Pricing in Context

In New Jersey, CPT code 86146 (Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement) carries an average Medicare payment of $24.91 — 1% above the national benchmark of $24.72. 34 providers across the state submitted claims for this procedure in 2023, performing 23.7K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Jersey is $115.99, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in New Jersey lands near $63.53, with self-pay cash prices typically around $50.58. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement cost in New Jersey?

The average Medicare payment for Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement in New Jersey is $24.91, which is 1% above the national average of $24.72. Providers in NJ typically bill $115.99 for this procedure.

What does Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement cost with insurance in New Jersey?

With commercial insurance in New Jersey, Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement costs an estimated $63.53. Without insurance, the estimated cash price is $50.58. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement in New Jersey?

34 providers in New Jersey billed Medicare for Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement in 2023, performing 23.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement cheaper in New Jersey than the national average?

No — Beta 2 Glycoprotein 1 Antibody (autoantibody) Measurement costs 1% above the national average in New Jersey. The state average Medicare payment is $24.91 compared to $24.72 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial